Endocrinology Practice Questions

Q: Which of the following statements regarding thyroid hormones is correct?

Majority of the circulating T3 remains in bound form. ### Explanation **Correct Option: A. Majority of the circulating T3 remains in bound form** Thyroid hormones (T3 and T4) are highly hydrophobic and require carrier proteins for transport in the blood [1]. Approximately **99.7% of T3** and **99.97% of T4** circulate in bound form. The primary binding proteins are **Thyroxine-Binding Globulin (TBG)**, transthyretin, and albumin [1]. Only the unbound (free) fraction is biologically active and capable of entering target cells [1]. **Why the other options are incorrect:** * **Option B:** In reality, only about **20%** of circulating T3 is directly secreted by the thyroid gland. The remaining **80%** is produced via the peripheral deiodination of T4 (pro-hormone) by Type 1 and Type 2 deiodinase enzymes in tissues like the liver and kidney. * **Option C:** TSH is the **most sensitive** screening and diagnostic test for primary hypothyroidism. Due to the negative feedback loop, even a slight decrease in T4 levels leads to a logarithmic increase in TSH, often making it elevated even before T4 falls below the normal range (Subclinical Hypothyroidism). * **Option D:** The fetal pituitary-thyroid axis is **independent** of the maternal axis. The placenta is largely impermeable to TSH. While small amounts of maternal T4 cross the placenta to support early brain development, the fetus begins synthesizing its own thyroid hormones by the end of the first trimester (approx. 12 weeks). **High-Yield Clinical Pearls for NEET-PG:** * **Potency:** T3 is 3–4 times more potent than T4 and has a much shorter half-life (1 day vs. 7 days for T4) [2]. * **Wolff-Chaikoff Effect:** Transient inhibition of thyroid hormone synthesis due to high iodine intake. * **Amiodarone:** A high-yield drug that can cause both hypo- and hyperthyroidism due to its high iodine content and structural similarity to T4.

Q: Steroid hormones are believed to enter target cells via:

Simple diffusion. **Explanation:** **1. Why Simple Diffusion is Correct:** The plasma membrane is a phospholipid bilayer, which acts as a barrier to water-soluble substances but allows lipid-soluble molecules to pass through easily. **Steroid hormones** (such as cortisol, aldosterone, estrogen, and testosterone) are derivatives of **cholesterol**, making them highly **lipophilic (hydrophobic)**. Because of this lipid solubility, they can dissolve directly into the lipid bilayer and cross the cell membrane via **simple diffusion** along their concentration gradient. Once inside, they typically bind to intracellular receptors (cytoplasmic or nuclear) to initiate genomic effects. **2. Why the Other Options are Incorrect:** * **Facilitated Diffusion:** This requires specific transmembrane proteins (channels or carriers) to transport molecules that are too large or polar to cross the bilayer alone (e.g., glucose via GLUT). Steroids do not require these transporters. * **Carrier-mediated Endocytosis:** This is an active process involving the engulfing of substances (like LDL or Iron/Transferrin). While some steroid-binding proteins are endocytosed, the free hormone itself enters via diffusion. * **Cholesterol-lined Pores:** This is a distractor. There are no specific "cholesterol-lined" anatomical pores designed for hormone entry; the entire membrane is inherently permeable to them. **3. NEET-PG High-Yield Pearls:** * **Thyroid Hormones (T3, T4):** Despite being lipophilic, they primarily enter cells via **carrier-mediated transport** (MCT8/MCT10), not simple diffusion. This is a common "trap" question. * **Mechanism of Action:** Steroid hormones have a **slow onset** but **long duration** of action because they alter gene transcription (Mobile Receptor Hypothesis). * **Exception:** Some steroids can have rapid, non-genomic effects via membrane-bound receptors (e.g., certain effects of progesterone).

Q: Where are the alpha-estrogen receptors located?

Nuclear receptors in breast. **Explanation:** Estrogen receptors (ERs) are members of the **nuclear receptor superfamily** of intracellular transcription factors. Estrogen, being a lipid-soluble steroid hormone, diffuses across the cell membrane to bind with these receptors. Upon binding, the receptor-ligand complex translocates to the nucleus (if not already present), binds to Estrogen Response Elements (EREs) on DNA, and regulates gene transcription. **Why Option B is Correct:** There are two main subtypes of estrogen receptors: **ER-alpha (ERα)** and **ER-beta (ERβ)**. ERα is the predominant subtype found in the **breast** (specifically mammary epithelium) and the uterus. Its activation is responsible for the proliferative effects of estrogen in these tissues. **Analysis of Incorrect Options:** * **Options A & C:** While a small fraction of estrogen receptors (GPER) are membrane-bound for rapid non-genomic signaling, the classic alpha-estrogen receptors are fundamentally classified as **nuclear receptors**. * **Option D:** While ERα is present in the ovaries (theca cells), **ER-beta (ERβ)** is the predominant isoform found in the granulosa cells of the ovaries. **High-Yield NEET-PG Pearls:** * **Location Summary:** ERα is primarily in the breast, uterus, and liver; ERβ is primarily in the ovaries, prostate, and colon. * **Clinical Correlation:** ERα status is a critical biomarker in breast cancer; ER-positive tumors are candidates for endocrine therapies like **Tamoxifen** (a SERM). * **Mechanism:** Steroid receptors (Estrogen, Progesterone, Testosterone) are typically **Type I nuclear receptors**, whereas Thyroid and Vitamin D receptors are **Type II** (already bound to DNA).

Q: In hypogonadotropic hypogonadism, what is the typical hormonal profile?

Both LH and FSH are decreased. ### Explanation **Underlying Concept:** The Hypothalamic-Pituitary-Gonadal (HPG) axis operates through a feedback loop. In **Hypogonadotropic Hypogonadism**, the primary defect lies in the **Hypothalamus** (decreased GnRH) or the **Anterior Pituitary** (decreased LH/FSH). Because the "tropic" hormones (LH and FSH) that stimulate the gonads are low, the gonads fail to produce sex steroids (testosterone or estrogen). This is a **secondary** or **central** failure. **Why Option A is Correct:** In this condition, the pituitary fails to secrete adequate Gonadotropins. Therefore, both **Luteinizing Hormone (LH)** and **Follicle-Stimulating Hormone (FSH)** are **decreased** (or inappropriately normal) in the presence of low sex steroids. **Why Other Options are Incorrect:** * **Option B:** Increased LH and FSH with low sex steroids characterize **Hypergonadotropic Hypogonadism** (Primary failure, e.g., Klinefelter syndrome or Turner syndrome). Here, the lack of negative feedback from the gonads causes the pituitary to overproduce gonadotropins. * **Options C & D:** LH and FSH usually move in the same direction in central or primary failure. Isolated elevations or depressions are rare and typically point to specific conditions like PCOS (high LH:FSH ratio) or specific pituitary adenomas, rather than classic hypogonadotropic hypogonadism. **High-Yield Clinical Pearls for NEET-PG:** * **Kallmann Syndrome:** The most common congenital cause of hypogonadotropic hypogonadism, characterized by **anosmia** (failure of GnRH neurons to migrate from the olfactory bulb). * **Differential:** If LH/FSH are high, the problem is in the **Gonads** (Primary). If LH/FSH are low, the problem is in the **Pituitary/Hypothalamus** (Secondary). * **Prostate Cancer Treatment:** GnRH *agonists* (like Leuprolide) initially increase LH/FSH but eventually cause down-regulation of receptors, leading to a state of "chemical" hypogonadotropic hypogonadism.

Q: Exposure to darkness leads to increased melatonin secretion. What mechanism brings this about?

Increasing the serotonin N-acetyl transferase activity. **Explanation:** The pineal gland acts as a "neuroendocrine transducer," converting light signals from the retina into the hormonal signal of melatonin. **1. Why the correct answer is right:** Melatonin is synthesized from **Tryptophan** via the following pathway: *Tryptophan → 5-Hydroxytryptophan → Serotonin → N-Acetylserotonin → Melatonin.* The rate-limiting enzyme in this pathway is **Serotonin N-acetyltransferase (SNAT)**. In darkness, postganglionic sympathetic fibers release **Norepinephrine**, which acts on **β-adrenergic receptors** in the pineal gland. This increases intracellular cAMP, which significantly activates SNAT. Consequently, serotonin is rapidly converted to N-acetylserotonin, leading to a surge in melatonin production. **2. Why the incorrect options are wrong:** * **Option A:** The Suprachiasmatic Nucleus (SCN) is the "master clock." While light inhibits the SCN's stimulation of the pineal gland, the specific biochemical mechanism for increased melatonin is the *activation* of the enzymatic pathway, not merely a decrease in SCN activity. * **Option C:** Hydroxy-indole-O-methyltransferase (HIOMT) is the final enzyme in the pathway. While it is necessary, it is not the primary regulatory/rate-limiting step triggered by darkness. * **Option D:** Darkness **increases** (rather than blocks) the release of norepinephrine from the superior cervical ganglion to stimulate melatonin synthesis. **High-Yield Facts for NEET-PG:** * **Precursor:** L-Tryptophan. * **Rate-limiting enzyme:** Serotonin N-acetyltransferase (SNAT). * **Light pathway:** Retina → Retinohypothalamic tract → SCN → Intermediolateral column (T1-T2) → Superior Cervical Ganglion → Pineal Gland. * **Clinical Pearl:** Melatonin levels peak between **2 AM and 4 AM**. It is used clinically for jet lag and delayed sleep phase syndrome.

Q: Which of the following is the most useful investigation for thyroid function?

TSH. **Explanation:** **Serum TSH (Thyroid Stimulating Hormone)** is considered the single most useful and sensitive initial screening test for evaluating thyroid function in the general population. **Why TSH is the Correct Answer:** The relationship between Serum TSH and Free T4 is **log-linear**; even a minor change in the concentration of free thyroid hormones results in a much larger, compensatory change in TSH levels from the anterior pituitary. Therefore, TSH is the first parameter to become abnormal in both subclinical hypothyroidism (high TSH) and subclinical hyperthyroidism (low TSH), often before the patient becomes symptomatic or T3/T4 levels fall outside the reference range. **Why Other Options are Incorrect:** * **T3 (Triiodothyronine):** While T3 is the biologically active form, it is the least sensitive for screening. In early hypothyroidism, T3 levels are often maintained within the normal range due to increased TSH stimulation. It is primarily useful for diagnosing T3-toxicosis. * **T4 (Thyroxine):** Total T4 levels are heavily influenced by changes in **Thyroxine-Binding Globulin (TBG)** levels (e.g., pregnancy, OCP use). While Free T4 is more accurate, it is still less sensitive than TSH for early detection of thyroid dysfunction. * **TRH (Thyrotropin-Releasing Hormone):** TRH stimulation tests are rarely used in modern clinical practice. They were historically used to distinguish between secondary and tertiary hypothyroidism but have been largely replaced by high-sensitivity TSH assays and MRI. **High-Yield Clinical Pearls for NEET-PG:** * **Best Screening Test:** TSH. * **Best test to monitor Thyroid Replacement (Levothyroxine):** TSH (wait 6–8 weeks after dose adjustment). * **Exception:** In **Secondary (Central) Hypothyroidism**, TSH is unreliable; **Free T4** is the investigation of choice to monitor treatment. * **Best test for early Hyperthyroidism:** TSH (suppressed).

Q: Sclerostin is produced by which type of bone cell?

Osteocytes. **Explanation:** **Correct Answer: A. Osteocytes** Sclerostin is a glycoprotein primarily secreted by **mature osteocytes** (cells embedded within the mineralized bone matrix). It acts as a potent negative regulator of bone formation. Mechanistically, sclerostin binds to LRP5/6 receptors on the surface of osteoblasts, thereby inhibiting the **Wnt signaling pathway**. This inhibition prevents osteoblast proliferation and differentiation, leading to decreased bone formation. When bone experiences mechanical loading, sclerostin production decreases, allowing Wnt signaling to trigger bone deposition. **Why other options are incorrect:** * **B. Osteoblasts:** While osteoblasts are the targets of sclerostin action, they do not produce it. Osteoblasts are responsible for bone matrix synthesis (osteoid). * **C. Osteoclasts:** These are myeloid-derived cells responsible for bone resorption. They do not produce sclerostin; however, sclerostin indirectly promotes their activity by increasing the RANKL/Osteoprotegerin (OPG) ratio. * **D. Chondrocytes:** These are cells found in cartilage. While they share a mesenchymal origin with bone cells, they are not the source of sclerostin in the context of bone remodeling. **High-Yield Clinical Pearls for NEET-PG:** * **Romosozumab:** A monoclonal antibody against sclerostin used in the treatment of severe osteoporosis. It has a dual effect: increasing bone formation and decreasing bone resorption. * **Van Buchem Disease & Sclerosteosis:** Rare genetic conditions caused by a deficiency in sclerostin, leading to excessive bone overgrowth (hyperostosis). * **The "Master Regulator":** Osteocytes are now considered the "master regulators" of bone remodeling because they sense mechanical strain and coordinate both osteoblast and osteoclast activity via sclerostin and RANKL.

Question 1

Parasympathetic stimulation of nerves innervating the islets of the pancreas will:

Accepted Answer

Increase secretion of insulin from B cells

Answer

Have no effect

Answer

Decrease secretion of insulin from B cells

Answer

Increase secretion of glucagon from B cells

Question 2

Which of the following statements regarding thyroid hormones is correct?

Accepted Answer

Majority of the circulating T3 remains in bound form

Answer

Only 50% of the circulating T3 is secreted by the thyroid

Answer

TSH estimation is not a sensitive test for the diagnosis of primary hypothyroidism

Answer

Fetal pituitary-thyroid axis is dependent to a large extent on the maternal pituitary-thyroid axis

Question 3

Steroid hormones are believed to enter target cells via:

Accepted Answer

Simple diffusion

Answer

Facilitated diffusion

Answer

Carrier-mediated endocytosis

Answer

Cholesterol-lined pores in the plasma membrane

Question 4

Where are the alpha-estrogen receptors located?

Accepted Answer

Nuclear receptors in breast

Answer

Membrane receptors in breast

Answer

Membrane receptors in ovaries

Answer

Nuclear receptors in ovaries

Question 5

In hypogonadotropic hypogonadism, what is the typical hormonal profile?

Accepted Answer

Both LH and FSH are decreased

Answer

Both LH and FSH are increased

Answer

LH is increased and FSH is decreased

Answer

LH is decreased and FSH is increased

Question 6

Exposure to darkness leads to increased melatonin secretion. What mechanism brings this about?

Accepted Answer

Increasing the serotonin N-acetyl transferase activity

Answer

Decreasing the activity of suprachiasmatic nuclei

Answer

Decreasing the hydroxy-indole-o-methyltransferase activity

Answer

Blocking the release of norepinephrine from sympathetic nerve terminals

Question 7

Which of the following hormones exerts the least effect on the calcium metabolism of bone tissue?

Accepted Answer

Norepinephrine

Answer

Androgen

Answer

Estrogen

Answer

Thyroid hormone

Question 8

An excess of which of the following hormones may be associated with increased sensitivity to epinephrine?

Accepted Answer

Thyroid hormone

Answer

Testosterone

Answer

Parathyroid hormone

Answer

Insulin

Question 9

Which of the following is the most useful investigation for thyroid function?

Accepted Answer

TSH

Answer

T3

Answer

T4

Answer

TRH

Question 10

Sclerostin is produced by which type of bone cell?

Accepted Answer

Osteocytes

Answer

Osteoblasts

Answer

Osteoclasts

Answer

Chondrocytes

Endocrinology — MCQs

Endocrinology — MCQs

On this page

Practice by Chapter

Want unlimited practice?